PRMT1 and Parkinson disease: In studies using neurotoxin-induced models of PD, PRMT1 can enhance dopaminergic cell apoptosis, potentially by promoting the overactivation of PARP1, nuclear translocation of AIF and subsequent depletion of energy supplies.